<bill session="115" type="h" number="2026" updated="2019-04-18T16:06:51Z">
  <state datetime="2017-04-06">REFERRED</state>
  <status>
    <introduced datetime="2017-04-06"/>
  </status>
  <introduced datetime="2017-04-06"/>
  <titles>
    <title type="official" as="introduced">To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.</title>
    <title type="short" as="introduced">Pharmaceutical Information Exchange Act</title>
    <title type="short" as="introduced">Pharmaceutical Information Exchange Act</title>
    <title type="display">Pharmaceutical Information Exchange Act</title>
  </titles>
  <sponsor bioguide_id="G000558"/>
  <cosponsors/>
  <actions>
    <action datetime="2017-04-06">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-04-06" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-04-07">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-01-17">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2018-01-17">
      <text>Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Health information and medical records"/>
    <term name="Medical research"/>
  </subjects>
  <amendments/>
  <summary date="2017-04-06T04:00:00Z" status="Introduced in House">Pharmaceutical Information Exchange Act

This bill amends the Federal Food, Drug, and Cosmetic Act to&#160;allow information about&#160;a new&#160;investigational medication or the investigational use of a medication&#160;approved&#160;by the Food and Drug Administration&#160;to be provided to health care entities if the information is based on reliable scientific evidence.</summary>
  <committee-reports/>
</bill>
